Androgen deprivation causes truncation of the C-terminal region of androgen receptor in human prostate cancer LNCaP cells

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Androgen receptor and its splice variants in prostate cancer

(2011) Simon Haile et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Regression of Castrate-Recurrent Prostate Cancer by a Small-Molecule Inhibitor of the Amino-Terminus Domain of the Androgen Receptor

(2010) Raymond J. Andersen et al.   CANCER CELL

Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant

(2010) Shihua Sun et al.   JOURNAL OF CLINICAL INVESTIGATION

Inhibitory mechanisms of the transcriptional activity of androgen receptor by resveratrol: Implication of DNA binding and acetylation of the receptor

(2010) Naoki Harada et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

26S Proteasome Activity Is Down-Regulated in Lung Cancer Stem-Like Cells Propagated In Vitro

(2010) Jing Pan et al.   PLoS One

ARA24/Ran enhances the androgen-dependent NH2- and COOH-terminal interaction of the androgen receptor

(2008) Naoki Harada et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The potential of proteasome inhibitors in cancer therapy

(2008) Jan Sterz et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

A Common Motif Targets Huntingtin and the Androgen Receptor to the Proteasome

(2008) Shweta Chandra et al.   JOURNAL OF BIOLOGICAL CHEMISTRY